CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0.398. It has been cited 9 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.0531
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
National Institute of General Medical Sciences
Grant: T32 GM008692
National Cancer Institute
Grant: P30 CA014520
National Cancer Institute
Grant: R01 CA215461
National Cancer Institute
Grant: T32 CA009135
National Institutes of Health
Grant: TL1 TR002375
Midwest Athletes Against Childhood Cancer (MACC) Fund
Grant: N/A
American Cancer Society Research Scholar Grant
Grant: RSG-19-104-01-LIB
National Science Foundation
Grant: Graduate Research Fellowship Program DGE-1747503
National Science Foundation
Grant: NSF 1810916 WiscAMP Bridge to the Doctorate
St. Baldrick’s Foundation
Grant: Empowering Pediatric Immunotherapy for Childhood C
NCATS NIH HHS
Grant: UL1 TR002373
FWCI
3.24
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals